Table 5 Effect of absence of staff, HIV testing commodities and PMTCT drugs on monthly MCH consultations in all clinics, post-intervention
N | OR | P value | |
|---|---|---|---|
Absence of MCH staff | |||
HIV-exposed infants starting follow-up visits | 67 | 0.20 | 0.200 |
Any HIV tests in HIV-exposed infants | 69 | 0.06 | 0.027 |
Serologic HIV tests in HIV-exposed infants | 69 | 0.10 | 0.030 |
Absence of testing supplies | |||
Pregnant women detected as HIV+ | 70 | 0.48 | 0.166 |
Any HIV tests in HIV-exposed infants | 70 | 0.90 | 0.812 |
Serologic HIV tests in HIV-exposed infants | 70 | 0.56 | 0.201 |
Absence of MCH drugs | |||
HIV + pregnant women initiating PMTCT | 69 | 0.56 | 0.463 |
HIV + women receiving PMTCT during childbirth | 69 | 0.32 | 0.196 |
HIV-exposed infants receiving PMTCT at birth | 69 | 0.32 | 0.193 |